ACRS
Aclaris Therapeutics Inc
4.40$
-16.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +650.0% | +33.3% | +235.0% | +367.4% | -15.6% | -16.5% | -30.3% | -13.7% | +8.3% | -6.5% | -43.7% | |
| – | +3,200.0% | +585.1% | +136.4% | +39.0% | -19.3% | -30.7% | +25.5% | +7.0% | +36.6% | -47.2% | +14.1% | |
| – | +4,270.4% | +671.5% | +38.3% | +69.4% | +195.6% | -78.7% | +191.8% | -49.6% | – | – | – | |
| – | -227.3% | – | -79.7% | +991.1% | -128.6% | – | – | – | – | +16.3% | -75.5% | |
| – | +21.6% | -54.2% | +432.3% | +9.8% | +19.0% | -71.9% | -32.0% | +96.4% | +116.4% | -90.8% | -8.3% | |
| – | +4,225.5% | -19.6% | -10.0% | – | +1,028.2% | -94.0% | -2,724.6% | – | +266.0% | -250.9% | – | |
| – | – | – | – | – | – | – | -59.6% | – | – | – | – | |
| – | +52.4% | +21.2% | -14.0% | +0.3% | -99.8% | +3,637.7% | -140.4% | -98.9% | +200.0% | – | – | |
| – | +0.0% | +0.0% | +0.0% | – | -202.5% | – | -205.2% | -100.0% | – | – | – | |
| – | +810.9% | +21.2% | -14.1% | +27.8% | -123.6% | – | +1,125.0% | -67.6% | -63.3% | +179.1% | -107.9% | |
| – | -177.5% | – | -149.1% | – | -157.3% | – | – | +239.2% | -130.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.